Leucadia National Corporation »

Zenas Biopharma shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Zenas Biopharma shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.8M 5.5M 1.04

More positions owned by Leucadia National Corporation

Spdr Gold Tr Gold Shs (GLD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust State Street Spd (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Select Sector Spdr Tr State Street Ene (XLE)
Amazon (AMZN)
Iren Ordinary Shares (IREN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
NVIDIA Corporation (NVDA)
Wal-Mart Stores (WMT)
Mastercard Incorporated Cl A (MA)
Ashland (ASH)
Broadcom (AVGO)
Meta Platforms Cl A (META)

View all positions for Leucadia National Corporation

Top funds holding Zenas Biopharma

Deerfield Management Company
Context Capital Management
Jpmorgan Chase & Co
Braidwell
Jane Street
Citadel Advisors
Leucadia National Corporation
Capstone Investment Advisors
Monashee Investment Management
D. E. Shaw & Co
Calamos Advisors
Graham Capital Management
Woodline Partners
Millennium Management
Aristeia Capital

View all funds holding Zenas Biopharma